Neurocrine Biosciences (NASDAQ:NBIX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Neurocrine Biosciences (NBIX) operate in?

Neurocrine Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Neurocrine Biosciences Stock (NASDAQ: NBIX) stock price, news, charts, stock research, profile.

Open	$120.28
Close	$118.35
Volume / Avg.	1.28M / 924.44K
Day Range	$117.00 - $120.28
52 Wk Range	103.63 - 157.98
Market Cap	$11.95B
P/E Ratio	36.28
Dividend Yield	-
Exchange	NASDAQ
RSI	30
Short Interest	2.47%
Days to Cover	1.87

Recent News

Neurocrine Shifts Focus To New Schizophrenia Treatment After Luvadaxistat Trial Misses Endpoint

Neurocrine Biosciences announced that its ERUDITE Phase 2 trial for luvadaxistat failed to meet its primary endpoint in treating cognitive impairment in schizophrenia. The company will halt development and focus on advancing other schizophrenia and depression candidates.

Vandana Singh

Intel, Moderna And Dollar General Were Among Top 10 Large Cap Losers In August: Are The Others In Your Portfolio?

10 worst performing large-cap stocks in August: Super Micro, Dollar General, Snap, PDD Holdings, Intel, Tencent Music, Gold Fields, Charles River, Moderna, Neurocrine Biosciences.

Lekha Gupta

Dollar General, Temu Parent PDD And Super Micro Computer Are Among Top 10 Large Cap Losers Last Week (Aug 25-Aug 31): Are The Others In Your Portfolio?

10 worst performing large-cap stocks in the last week. Dollar General, Super Micro Computer, Okta, Pure Storage, Neurocrine Biosciences among them.

Lekha Gupta

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

About Neurocrine Biosciences, Inc.

Sector

Health Care

Industry

Biotechnology

Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in t...

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

How do I buy Neurocrine Biosciences (NBIX) stock?

You can purchase shares of Neurocrine Biosciences (NASDAQ:NBIX) through any online brokerage.

View our list of the best stock brokerages

Who are Neurocrine Biosciences (NBIX) competitors?

Other companies in Neurocrine Biosciences’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).

What is the forecast, or price target, for Neurocrine Biosciences (NBIX) stock?

There is no analysis for Neurocrine Biosciences to provide a consensus price target.

What is the current price for Neurocrine Biosciences (NBIX)?

The stock price for Neurocrine Biosciences (NASDAQ: NBIX) is $118.35 last updated September 20, 2024 at 4:04 PM EDT.

Does Neurocrine Biosciences (NBIX) pay a dividend?

There are no upcoming dividends for Neurocrine Biosciences.

When is Neurocrine Biosciences (NASDAQ:NBIX) reporting earnings?

Neurocrine Biosciences does not have any upcoming earnings scheduled.

Is Neurocrine Biosciences (NBIX) going to split?

There is no upcoming split for Neurocrine Biosciences.

What sector and industry does Neurocrine Biosciences (NBIX) operate in?

Neurocrine Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Get Our Top Trade Ideas Delivered Daily - 65% Off Now